Abstract
Maytenus senegalensis Lam. (Celastraceae) leaves are traditionally used in West Africa for the management of cancer and other disorders associated with inflammation. In this study, bioactivity-guided fractionation of the methanol leaf extract of Maytenus senegalensis led to the isolation of 11 compounds, including the new phenyldilactone, maysedilactone (1). All isolated compounds were tested for cytotoxicity against mouse lymphoma cell line (L5178Y). Only (−) epigallocathechin showed high cytotoxicity and completely inhibited cell growth at the investigated dose of 10μg/mL. This result supports the claimed efficacy of Maytenus senegalensis leaf extract in ethnomedicinal treatment of cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
